# Determining Equivalence Dose for Oral Versus Sublingual Administration of Tacrolimus in Hepatic Receptors

> **NCT02608606** · NA · COMPLETED · sponsor: **Pontificia Universidad Catolica de Chile** · enrollment: 20 (actual)

## Conditions studied

- Evidence of Liver Transplantation
- Effects of Immunosuppressant Therapy

## Interventions

- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT02608606
- **Lead sponsor:** Pontificia Universidad Catolica de Chile
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02608606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02608606, "Determining Equivalence Dose for Oral Versus Sublingual Administration of Tacrolimus in Hepatic Receptors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02608606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*